RE:RE:2021 ADRIQ Innovation Award The award is deserved for their potentially great scientific achievement with TH-1902 and the Sort1+ platform, but it would be nice if these scientific achievements would translate into better market performance more quickly. TH ha long been very good on the scinetific end of their operations but weak in marketing and public/investor relations. Like really, really weak. Unacceptably weak. So, I hope they enjoy their award but simultaneously understand that investors like they need to significantly up their game on the other aspects of the business. If you get fast track status, attract cancer experts like Soleus to invest in TH, recruit the recently retired CMO of Pfizer as a Scientific consultant (and already having one of the top endocronoligists in the world as another scientific consultant) but can't get investors to properly understand the significance of these developments during a period of time when it should be easier than ever to do so, you really need to make big changes in how you approach the problem. In TH's case, its long, long term issues with investor engagement somehow has only gone from bad to worse in the last few years. It is so bad now that it should not be too hard to start seeing a positive change in trend with any sensible and concerted effort to rectify the problem.
Bucknelly21 wrote: Another Qubec based non event lol